Baylee Polzin

ORCID: 0009-0004-5146-8970
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer survivorship and care
  • Tryptophan and brain disorders
  • Gun Ownership and Violence Research
  • Family Support in Illness
  • Public Health Policies and Education
  • Injury Epidemiology and Prevention
  • Cancer, Stress, Anesthesia, and Immune Response

University of Louisville
2023-2025

Importance Patients with head and neck cancer experience high rates of depression. Depression systemic inflammation have been found to be associated in numerous types, often independently from disease status. Depression-related may elevate the risks for poor tumor response treatment early mortality, comprises a mechanism by which depression is survival cancer. Objective To assess mediation pathways incorporating pretreatment depressive symptoms, inflammation, posttreatment on overall among...

10.1001/jamaoto.2024.0231 article EN cc-by JAMA Otolaryngology–Head & Neck Surgery 2024-03-28

Abstract Introduction Obstructive sleep apnea (OSA) is the most common indication for adenotonsillectomy (T&A) in pediatric population. Though polysomnography (PSG) gold standard OSA diagnosis, role PSG findings, patient comorbidities, and their interactions play predicting perioperative events remains unclear. The aim of this study to evaluate correlation between preoperative comorbidities specific events. Methods This was a single center retrospective involving children under 18 years...

10.1093/sleep/zsaf090.0987 article EN SLEEP 2025-05-01

Abstract Background Head and neck cancers (HNC) are associated with high rates of anxiety. Anxiety has been linked to biological pathways implicated in cancer progression, though little is known about its effects on overall survival. We hypothesized that higher pretreatment anxiety levels patients HNC would predict poorer 2‐year survival expected this relationship be mediated by both systemic inflammation tumor response treatment. Methods Patients ( N = 394) reported symptomatology via the...

10.1002/pon.6375 article EN Psycho-Oncology 2024-07-01
Coming Soon ...